Brockman Testifies: Musk Wanted OpenAI to Go Commercial, Board Shakeup Revealed
Brockman Testifies: Musk Wanted OpenAI to Go Commercial, Board Shakeup Revealed
OpenAI president Greg Brockman recounts a fiery 2017 meeting with Elon Musk and talks of removing board members as governance tensions surface in a high-stakes trial.
Greg Brockman, OpenAI’s president, testified about a fiery 2017 meeting with Elon Musk that would echo through the organization's governance years later. He described how the exchange grew heated and said he feared Musk’s reaction, recalling, "I actually thought he was going to hit me." The testimony also detailed later efforts to remove several board members in the wake of that confrontation, painting a picture of early friction as the nonprofit sought to chart its path in a rapidly evolving field.
The proceedings unfold in a high-profile case pitting Musk against OpenAI, focused in part on Musk’s push to shift the research group toward more commercial aims. Brockman testified that Musk favored changing OpenAI’s structure to a more market-oriented model, challenging the nonprofit framework that had framed the organization’s initial mission to prioritize safety and public benefit over profit. The tension between mission and market remains central as the trial unfolds, with observers watching how governance choices could influence the future of AI development.
Additional testimony from the session highlights concerns about governance, board dynamics, and how to balance openness with control in a space where breakthroughs race ahead of policy. The public record from the trial is shaping discussions among technologists, investors, and policymakers about how much influence private leadership should exert over frontier AI projects born from philanthropic ideals but operating under competitive pressures.
As the case continues, the conversations around OpenAI’s direction—whether to maintain a nonprofit ethos or embrace a more commercial model—will likely reverberate beyond the courtroom, signaling how big tech and science navigate the tricky line between innovation and governance.